Candace Y.W. Lee

Pharmacodynamics Pharmacodynamics of a Novel Designer Natriuretic Peptide, CD‐NP, in a First‐in‐Human Clinical Trial in Healthy Subjects

Candace Y.W. Lee, Horng H. Chen, Ondřej Lisý et al. · The Journal of Clinical Pharmacology · 2009 · 109 citations · Full text

Medicine, Cardiology, Pharmacology +16

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

Rika Kawakami, Candace Y.W. Lee, Christopher G. Scott et al. · Clinical Pharmacology & Therapeutics · 2017 · 38 citations · Full text

Medicine, Cardiology, Pharmacology +16

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing<i>in vivo</i>and<i>ex vivo</i>actions

Candace Y.W. Lee, Brenda K. Huntley, Daniel McCormick et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2015 · 30 citations · Full text

Medicine, Nephrology, Pharmacology +13

A pilot study of paternal drug exposure: The Motherisk experience

Candace Y.W. Lee, Cheng Jin, Andrea M. Mata et al. · Reproductive Toxicology · 2010 · 24 citations

Pharmacy, Toxicology, Reproductive Toxicology +10

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome

Cathérine Gebhard, Éric Rhéaume, Colin Berry et al. · PLoS ONE · 2017 · 15 citations · Full text

Medicine, Cardiology, Clinical Sciences +14